Study of oxycodone hydrochloride for the perioperative management of burn patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067870

Enrollment

Unknown

Registered

2023-01-30

Start date

2022-03-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative management of burns

Interventions

Oxy group:Oxycodone hydrochloride

Suf group:sufentanil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing general anesthesia in burn department, aged 18-65 years; 2. ASA grade I-II, cardiac function I-II, and no serious systemic disease; 3. Clear consciousness and good compliance; 4. Good communication in Mandarin

Exclusion criteria

Exclusion criteria: 1. Patients with obvious dysfunction of vital organs; 2. Neurological and mental system diseases or taking corresponding drugs; 3. Patients with contraindications to the use of common anesthetic drugs.

Design outcomes

Primary

Measure	Time frame
mean arterial pressure;heart rate;	—

Secondary

Measure	Time frame
Self-Rating Anxiety Scale, SAS;visual analogue scale of anxiety, VAS-a;Visual analogue scale, VAS;MMSE, Mini-mental State Examination;IL-6;C reactive protein;procalctionin;	—

Countries

China

Contacts

Public ContactLi Mengmeng

Department of Anesthesiology of the Fourth Medical Center, Chinese PLA General Hospital

mmli304@163.com+86 13401000778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026